Remote FDA Inspection Readiness Assessments
Prepare for FDA inspections from anywhere. Our remote FDA inspection readiness assessments help medical device, pharmaceutical, and combination product manufacturers evaluate compliance, identify gaps, and strengthen inspection readiness before regulators arrive.
Remote Quality System Assessments
Remote quality system assessments evaluate whether an organization’s quality management system is prepared for regulatory inspection. The review typically includes procedures, quality manuals, CAPA systems, complaint handling, document control, training records, validation records, and management responsibility. The objective is to determine whether the quality system aligns with FDA regulatory expectations and recognized quality standards. Remote assessments allow organizations to securely share documentation while receiving structured feedback on compliance gaps and potential inspection risks.
Remote CGMP Compliance Reviews
Remote CGMP compliance reviews focus on manufacturing and quality control systems that support product safety, consistency, and regulatory compliance. The review typically examines manufacturing procedures, batch records, deviation investigations, validation activities, laboratory controls, and data integrity practices. By evaluating documentation and operational controls before an inspection occurs, organizations can identify potential deficiencies and strengthen compliance with current Good Manufacturing Practice requirements.
Remote QMSR readiness assessments evaluate whether medical device manufacturers are prepared for inspections under the FDA Quality Management System Regulation framework. The review examines design controls, risk management, supplier controls, production processes, complaint handling, and CAPA effectiveness. The goal is to identify compliance gaps and strengthen documentation and quality system implementation before regulatory inspections occur.
Remote QMSR Readiness Assessments
Remote FDA inspection readiness assessments under Remote Regulatory Assessments (RRA)
Mocking a remote FDA inspection helps organizations evaluate their regulatory compliance before an official inspection. These assessments allow medical device, pharmaceutical, biotechnology, and combination product manufacturers to review their quality systems, manufacturing controls, and documentation practices in a structured manner. Through secure document sharing and virtual meetings, CIRG can review procedures, quality records, and compliance systems without requiring onsite visits. This approach provides an efficient way to identify potential compliance gaps and strengthen inspection preparedness. Remote assessments often focus on key regulatory areas, including quality management systems, current Good Manufacturing Practice compliance, CAPA effectiveness, complaint handling, validation documentation, and management oversight. Manufacturers benefit from an objective regulatory perspective that highlights areas requiring improvement before an FDA investigator arrives. By identifying risks early, companies can implement corrective actions, improve internal processes, and strengthen their overall inspection readiness, while minimizing the risk of regulatory observations or enforcement actions.